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This study was designed to determine the eﬃcacy of two novel type-four resistant starches (RS4) on postprandial glycemia and
ratings of fullness. Volunteers (n = 10) completed completed ﬁve interventions designed to determine the glycemic and satiety
(fullness) eﬀects of the starches (38g,) alone and when added on top of available carbohydrate. The dose of the starches provided
30g of resistant starch per treatment. The treatments were: commercial resistant starch added to water (PF−), noncommercial
resistant starch added to water (PR−), dextrose solution (DEX, 50g), and DEX with PenFibe starch (PF+), and DEX with the non-
commercialstarchadded(PR+).Bloodglucosewasmeasuredinthefastedstateandfollowingtherandomlyassignedtreatmentsat
30, 45, 60, 90, and 120 minutes post-consumption. A visual analog scale was used to determine fullness at each time point. There
were no diﬀerences in the glucose incremental areas under the curve (iAUC) for PF+ and PR+ compared with DEX. The PF−
and PR− treatments had decreased (P<0.05) iAUCs for glucose compared with DEX, PF+, and PR+. There were no treatment
diﬀerences for RoF. The dose (38g) of starches did not to alter glucose responses when added on top of 50g of dextrose.
1.Introduction
Diabetes, obesity, and cardiovascular diseases are inter-
related, with diet being one factor that links them all
together. Speciﬁcally, the current obesity epidemic has been
suggested to be a result of increased carbohydrate intake
[1], while dietary fat has frequently been touted as the
primary dietary culprit in the cause of many deleterious
metabolicconditions.Asanation,weincreasedcarbohydrate
consumption during the latter years of the past century
as the obesity epidemic began to surge [1]. While it is
laudable to try to change the behavior of individuals so
they choose other foods, it might be more eﬀective in the
short term to address this nutritional issue by providing
bioactive compounds that “behave” like traditional starch
yet elicit more favorable metabolic outcomes (acutely and
chronically). In other words, let people continue to choose
some of the foods they prefer, but make those foods healthier
by incorporating bioactive ingredients.
To that end, incorporating resistant starches into foods
by substituting them for the typical starch has been shown
to acutely decrease postprandial glucose and insulin [2].
There are ﬁve types of resistant starch, with RS types 2, 3,
and 4 tending to be studied more frequently. Also, there
are varieties of resistant starch within each type [3]. Gram
for gram, some resistant starches have been reported to
elicit minimal glucose and insulin excursions compared with
similar amounts of dextrose [2] and are easily incorporated
into regular food items with minimal aversion by consumers
[4]. Given the number of resistant starches commercially
available, there is a paucity of evidence from human trials
illustrating the eﬀects various types of resistant starches
have on glucose metabolism. Likewise, some consumers
are looking to food to assist them with regulating food
intake and/or regulating blood glucose. There is evidence
that resistant starch might be able to achieve this by
aﬀecting satiety and subsequent food intake, and attenuating
postprandial glycemia and insulinemia [2, 5]. To complicate
matters, Behall et al. [6] reported that it is imperative that
individual starches and ﬁbers be tested for eﬃcacy given the
unique structure and function qualities of starches that are
quickly becoming available. For example, Haub et al. [7]2 J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m
observed that speciﬁc forms of RS2 and RS4 elicit diﬀerent
glycemic responses when compared at the same dose.
While cross-linked RS4 has been shown to elicit sig-
niﬁcant reductions in glycemia and insulinemia [2], newer
versions are being formulated and might provide even
greater and/or diﬀerent health impacts. One new version
of RS4 is commercially available but has not been clinically
tested to determine its eﬃcacy to assist with regulating
blood glucose and minimizing hyperglycemia. Therefore,
the purpose of this study was to determine the glycemic
and satiety eﬀects of novel forms of RS4, derived from
potato starch. The hypotheses were that consuming the
RS4 treatments would not aﬀect glycemia compared with a
dextrose-only controlsolution; andwouldincrease ratings of
fullness when added to dextrose control solution.
2. Methods
2.1. Subjects. The Institutional Review Board of Kansas State
Universityapprovedthestudy,andwritteninformedconsent
wasobtained fromallvolunteers prior to thestudy. Inclusion
criteria were no diagnosis of acute or chronic metabolic
andcardiovasculardiseases,freeofgastrointestinaldisorders,
body mass index of 20–30kg/m2, and nonsmokers. Ten
adults were recruited and completed the study.
2.2. Study Design. A l lt r i a l sw e r ep e r f o r m e da tt h eH u m a n
Metabolism Laboratory at Kansas State University. Volun-
teers completed ﬁve trials via a single-blind randomized
crossover design (we did not alter the water to match the
taste/color of the dextrose solution). However, neither the
subject nor the technician knew which RS treatment they
were receiving. During each visit, volunteers consumed one
of the following: dextrose solution of 50g oral glucose
tolerance beverage (DEX), 38g of PF mixed into DEX (PF+),
38g of PR mixed into DEX (PR+), 38g of PF mixed in to
water (PF−), and 38g of PR mixed into water (PR−). The
doses of RS were chosen to provide 30g of resistant starch
as 80% of each resistant starch was determined to contain
RS and dietary ﬁber (Table 1). The resistant starches were
selected as they are novel, were uniquely produced using
proprietary techniques, and had not been clinically tested
for eﬃcacy regarding their eﬀects on glycemia as resistant
starches do not necessarily elicit the same glycemic response
[7].Thetreatmentswererandomlyadministeredincrossover
fashion using a Latin square design.
After providing informed consent, as approved by the
University Research Compliance Oﬃce at Kansas State
University, volunteers were enrolled into the study. For
testing, volunteers arrived to the laboratory in a 10-hour
fasted state. The fasting capillary blood samples were drawn
by ﬁnger stick prior to drinking the assigned treatment for
that day. Volunteers were allowed 10 minutes to ingest the
treatment.Theremainingbloodsampleswerecollectedat30,
45, 60, 90, and 120min after ingesting the treatment. Blood
sampleswereanalyzedinduplicateforglucoseconcentration
using a YSI 2300 STAT (Yellow Springs, OH).
After blood was collected, the participants were provided
a visual analog scale (Satiety Labeled Intensity Magnitude
Table 1: The nutrient composition as provided per 38g of each
ingredient.
PR PF
Energy (kJ)
Total 129.2 129.2
Net 25.8 25.8
Ash (g) 1.6 1.6
Carbohydrates (g) 32.3 32.3
Dietary ﬁber (g) 30.4 30.4
Resistant starch (g) 30.4 30.4
Sodium (g) 0.3 0.3
Calcium (mg) 16 16
Phosphorous (g) 0.4 0.4
Moisture (g) 14 14
PR = noncommercial resistant starch
PF = commercial resistant starch (PenFibe).
(SLIM) scale) to provide a rating of fullness (RoF) as used
by others [8]. Volunteers were not shown previous surveys
beforethenexttreatment.Attheconclusionofthestudy,one
technician (blind to treatments) recorded the individual RoF
responses.
2.3. Statistics. The incremental area under the curve (iAUC)
was calculated for glucose using the trapezoid model (Prism
v5, GraphPad). A repeated measures analysis of variance
was used to determine the presence of signiﬁcant main
and interaction eﬀects, and Bonferroni post-hoc assessments
were performed to determine between treatment eﬀects and
signiﬁcance set at P = 0.05 (Prism v5, GraphPad).
3. Results
3.1.GlycemiaandFullness. Therewasasigniﬁcant(P<0.05)
diﬀerence between the two water trials and three dextrose
trials, with the water + RS trials eliciting a signiﬁcantly
decreased glycemic response compared with the three dex-
trose trials (Figure 1). There were no treatment diﬀerences
(P>0.05) within the three DEX treatments (DEX, PR+, and
PF+) or within the two water treatments (PR− and PF−).
There was a signiﬁcant main eﬀect for time in PR+, PF+, and
DEX,whiletherewerenotimeeﬀectsfollowingtheingestion
of 38g of each resistant starch mixed with water. The PR+
and PF+ treatments with 38g of potato-derived modiﬁed
starchesaddedtoDEXdidnotincreasetheglycemicresponse
compared with DEX alone. There were no treatment eﬀects
for RoF (Figure 2).
4. Discussion
This study illustrates that two novel potato-derived resistant
starches did not elicit a glycemic response when added to
296mL of water. Likewise, there was no treatment eﬀect of
each RS4 added to DEX when compared to DEX alone. The
glycemic results of the present study are similar to data from
our previous assessment of a wheat-derived RS4 [7] in thatJ o u r n a lo fN u t r i t i o na n dM e t a b o l i s m 3
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Figure 1: (a) The glucose responses to 38g of resistant starches with water only (PR− and PF−), with 50g of dextrose (PR+ and PF+), and
50g of dextrose only (DEX). ∗ = P<0.05 for diﬀerences between PF− and PR− compared with DEX, PF+, and PR+, from 30 minutes to
90 minutes, means ± SD. (b) The iAUC values for each treatment. ∗ = diﬀerent (P<0.0001) from PF− and PR−, means ± SEM.
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Figure 2: The satiety responses, using the Satiety Labeled Intensity
Magnitude scale (SLIM), to consuming 38g of resistant starches
with water, (PF− and PR−), with 50g of dextrose (PF+ and PR+),
and 50g of dextrose only (DEX), means ± SD.
the excursion from baseline was minimal when PF and PR
were ingested when added to water. The treatments did not
diﬀer in RoF.
The acute glycemic eﬀect of resistant starch, regardless
of type, has been studied extensively and has been shown
to decrease glucose and insulin when ingested as part of a
food [2, 6, 9], but few studies to date have concomitantly
investigated the eﬀects on satiety. A study by Raben et al.
[10], who also used potato starch, had volunteers ingest
meals containing raw or pregelatinized potato starch on
postprandial glucose and insulin concentrations and satiety.
They observed that the replacement of raw potato starch
(increased RS content) for pregelatinized starch elicited
decreased glucose and insulin levels. Contrary to the present
observations, they reported that the resistant starch meal
elicited a signiﬁcant (P<0.05) decrease in fullness and
satisfaction. The diﬀerence between their observations and
those of the present study are likely due to the methods
of incorporating the resistant starch into the treatments
that were ingested. Raben et al. [10] replaced digestible
starch with resistant starch, while we added the starch to
the digestible carbohydrate. Thus, the treatments used by
Rabenetal.didnotusetreatmentsthathadequalamountsof
readily digestible starch. Since the resistant starch treatment
had 50% less energy from readily digestible starch, their
decreased postprandial glucose and insulin responses are
expected and are in agreement with the glucose diﬀerences
observed in the present study between the PF− and PR−
treatments when compared with DEX, PF+, and PR+
treatments, as the PF− and PR− treatments did not contain
50g of dextrose. The diﬀerence in satiety results reported
between studies may, also, be due to the energy diﬀerences of
the meals reported by Raben et al. [10], as their RS treatment
was reported to contain 367kJ, while the pregelatinized
starch meal contained 917kJ. However, a study by Leeman et
al.[11]supportsthesatietyresponsesobservedinthepresent
study as they reported no diﬀerence in ratings of satiety for
potatofoods(Frenchfriesandboiledpotatoes)withdiﬀering
levels of energy content, indicating that factors other than
energy content, such as energy density [12], may need to
be taken into account when assessing satiety and subsequent
energy intake.4 J o u r n a lo fN u t r i t i o na n dM e t a b o l i s m
The present data, also, support the notion that postpran-
dial glycemia and satiety responses may not always coincide.
Even though subjects were consuming more energy with
each dextrose treatment (PF+, PR+, and DEX), the reported
satiety responses were not diﬀerent from those observed
with PF− and PR−. This observation has been previously
reported [13]. An explanation for the lack of an RoF eﬀect
mightbethatthebeveragesdidnotreachaportionthreshold
to elicit a satiety response [11].
The limitations of this study are as follows: the starches
were not incorporated into a food (bread, muﬃn, etc.), RoF
could have been inﬂuenced by volume of intake as the PF+
and PR+ treatments (88g of carbohydrate) had a greater
volumethantheDEXtrial(50gofcarbohydrate),thesample
size was powered for glycemia and not fullness, only one
outcome of satiety was assessed. Even with shortcomings,
this study is signiﬁcant as it illustrates that glycemia did not
inﬂuence RoF indicating that beverage-induced increases in
blood glucose do not appear to impact RoF. Future studies
need to measure intake overtime and take more measures of
satiety to better understand how results from acute studies
translate to habitual eating.
In conclusion, this study presents novel data regarding
the combined physical (glucose) and psychological (satiety)
eﬀects of a potato-derived resistant starch. These data
indicate that 38g of PF and PR added to water do not aﬀect
capillary glucose over two hours. There was no treatment
eﬀect for RoF. Likewise, when 38g of PF and PR were added
on top of 50g of dextrose (88g of carbohydrate), those resis-
tant starches did not aﬀect glucose or satiety responses when
compared with the DEX (50g of carbohydrate) treatment.
Since the addition of these starches did not aﬀect blood
glucose, these RS products might be useful substitutions for
standard rapidly digestible starches to decrease postprandial
glucose, and likely insulin, to better control blood glucose
when incorporated into a food product. However, those
foods would need to be clinically tested to insure the eﬀects
translate.
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